DK2575795T3 - Stabiliseret formulering omfattende omega-3 fedtsyrer og anvendelse af fedtsyrerne til hudpleje og/eller sårpleje - Google Patents

Stabiliseret formulering omfattende omega-3 fedtsyrer og anvendelse af fedtsyrerne til hudpleje og/eller sårpleje Download PDF

Info

Publication number
DK2575795T3
DK2575795T3 DK11730740T DK11730740T DK2575795T3 DK 2575795 T3 DK2575795 T3 DK 2575795T3 DK 11730740 T DK11730740 T DK 11730740T DK 11730740 T DK11730740 T DK 11730740T DK 2575795 T3 DK2575795 T3 DK 2575795T3
Authority
DK
Denmark
Prior art keywords
skin care
fat acids
formula including
including omega
stabilized formula
Prior art date
Application number
DK11730740T
Other languages
English (en)
Inventor
Gudmundur Fertram Sigurjonsson
Biljana Llievska
Baldur Tumi Baldursson
Original Assignee
Kerecis Ehf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kerecis Ehf filed Critical Kerecis Ehf
Application granted granted Critical
Publication of DK2575795T3 publication Critical patent/DK2575795T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK11730740T 2010-05-26 2011-05-24 Stabiliseret formulering omfattende omega-3 fedtsyrer og anvendelse af fedtsyrerne til hudpleje og/eller sårpleje DK2575795T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34835710P 2010-05-26 2010-05-26
PCT/IB2011/001113 WO2011148247A1 (en) 2010-05-26 2011-05-24 Stabilized formulation comprising omega-3 fatty acids and use of the fatty acids for skin care and/or wound care

Publications (1)

Publication Number Publication Date
DK2575795T3 true DK2575795T3 (da) 2019-11-04

Family

ID=44454608

Family Applications (1)

Application Number Title Priority Date Filing Date
DK11730740T DK2575795T3 (da) 2010-05-26 2011-05-24 Stabiliseret formulering omfattende omega-3 fedtsyrer og anvendelse af fedtsyrerne til hudpleje og/eller sårpleje

Country Status (5)

Country Link
US (3) US8568795B2 (da)
EP (2) EP3593794A1 (da)
DK (1) DK2575795T3 (da)
PL (1) PL2575795T3 (da)
WO (1) WO2011148247A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3593794A1 (en) 2010-05-26 2020-01-15 Kerecis EHF Stabilized formulation comprising omega-3 fatty acids and use of the fatty acids for skin care and/or wound care
KR102071733B1 (ko) * 2012-01-11 2020-01-30 애들레이드 리서치 앤드 이노베이션 피티와이 리미티드 고형 배지 상에 저장된 생물학적 샘플 중의 지방산들을 안정화시키고 분석하는 방법
JP6058434B2 (ja) * 2012-03-30 2017-01-11 花王株式会社 油脂組成物
US20140249618A1 (en) * 2013-02-18 2014-09-04 Elutin, Inc. Site specific drug delivery wraps, systems and methods of use thereof
EP2767293A1 (de) 2013-02-19 2014-08-20 Paul Hartmann AG Zusammensetzung zur beschleunigten Wundheilung geschädigten Gewebes
US20160074453A1 (en) * 2014-09-11 2016-03-17 Umm Al-Qura University A method and composition using myrrh, dill and peel of pomegranate as a natural remedy for chronic wounds
US10413528B2 (en) * 2014-10-20 2019-09-17 John H. Plumb Methods to inhibit infection during wound healing with topical compositions including amino acids
DE202018006387U1 (de) 2017-06-13 2020-03-20 Mary Kay, Inc. Kosmetikzusammensetzungen und deren Verwendung zur Straffung der Haut
EP3675807A1 (en) 2017-08-30 2020-07-08 Unilever N.V. A personal care composition
CN111182881B (zh) * 2017-08-30 2023-08-11 联合利华知识产权控股有限公司 个人护理组合物
WO2019177594A1 (en) 2018-03-13 2019-09-19 Multi-Chem Group, Llc Multifunctional friction reducers
WO2020223093A1 (en) 2019-04-30 2020-11-05 Bayer Healthcare Llc Topical analgesic gel compositions
WO2020223097A1 (en) 2019-04-30 2020-11-05 Bayer Healthcare Llc Topical analgesic compositions
WO2021255291A1 (en) * 2020-06-18 2021-12-23 The University Of Bristol Fatty acid complexes of coronavirus spike protein and their use
US20240065979A1 (en) * 2020-12-29 2024-02-29 One Idea LLC Protection of Polyunsaturated Fatty Acids, Lipid-Soluble Vitamins, and Lipid-Soluble Medicaments from Oxidation
CN117982468A (zh) * 2023-12-29 2024-05-07 武汉市第三医院 一种erk激动剂促进糖尿病足创面愈合应用及药物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1274734B (it) 1994-08-25 1997-07-24 Prospa Bv Composizioni farmaceutiche contenenti acidi grassi poliinsaturi, loro esteri o sali, unitamente a vitamine o provitamine antiossidanti
AUPP887399A0 (en) * 1999-02-24 1999-03-25 Bartlett Grain Pty Ltd Animal feed formulae for the nutritional enrichment of foodstuffs
JP2003113017A (ja) * 2001-09-28 2003-04-18 Kentetsuku:Kk 消臭魚油含有化粧品
US20060251750A1 (en) * 2002-09-30 2006-11-09 Tabor Aaron T Soy formulations and their use in skin care
GR1004395B (el) 2002-12-03 2003-11-28 Αθανασιος Λ. Γιαννακοπουλος Μεθοδος και συσταση ειδικου προσμειγματος ζωοτροφων για την παραγωγη αυγων ωμεγα ή ω-3 αυγων βελτιωμενης συνθεσης, των βιο-ωμεγα 3 αυγων
WO2004060412A1 (en) 2002-12-31 2004-07-22 Ossur Hf Wound dressing
ES2221804B1 (es) * 2003-06-18 2006-04-01 Lipofoods, S.L. Microcapsulas para la administracion de ingredientes activos.
US20060198800A1 (en) * 2003-08-14 2006-09-07 Natalie Dilallo Skin care compositions including hexapeptide complexes and methods of their manufacture
TW200806184A (en) * 2006-04-11 2008-02-01 Martek Biosciences Corp Food products comprising long chain polyunsaturated fatty acids and methods for preparing the same
MX2009001957A (es) * 2006-08-23 2009-03-05 Kellog Co Barra de cereal formada en frio fortificada con acidos grasos omega-3 y procesos para elaborarla.
WO2008073376A2 (en) 2006-12-11 2008-06-19 Keratec, Ltd. Porous keratin construct and method of making the same
GB2458466A (en) 2008-03-18 2009-09-23 Kartar Singh Lalvani Composition for hair, skin and nail health maintenance
US20100021573A1 (en) * 2008-07-22 2010-01-28 Michael J Gonzalez Compositions and methods for the prevention of cardiovascular disease
JP5724108B2 (ja) * 2009-04-22 2015-05-27 メドスキン ソリューションズ ドクター ズベラック アーゲーＭｅｄＳｋｉｎ Ｓｏｌｕｔｉｏｎｓ Ｄｒ．Ｓｕｗｅｌａｃｋ ＡＧ 凍結乾燥組成物
EP2946784A3 (en) 2009-05-29 2016-04-13 New Chapter, Inc. A therapeutic composition comprising salmon oil and extracts of rosemary and oregano
US9011936B2 (en) * 2009-10-16 2015-04-21 Naturex, S.A. Extract of Rosmarinus officinalis L. leaves for pharmaceutical applications
KR20120115965A (ko) 2009-11-06 2012-10-19 알콘 리서치, 리미티드 안구 건조의 완화를 위한 영양 보충제
EP3593794A1 (en) 2010-05-26 2020-01-15 Kerecis EHF Stabilized formulation comprising omega-3 fatty acids and use of the fatty acids for skin care and/or wound care

Also Published As

Publication number Publication date
US20140213649A1 (en) 2014-07-31
EP2575795B8 (en) 2019-10-23
PL2575795T3 (pl) 2020-06-01
US20110293755A1 (en) 2011-12-01
EP3593794A1 (en) 2020-01-15
US20140050808A1 (en) 2014-02-20
WO2011148247A1 (en) 2011-12-01
EP2575795B1 (en) 2019-09-04
EP2575795A1 (en) 2013-04-10
US8691298B2 (en) 2014-04-08
US8945636B2 (en) 2015-02-03
US8568795B2 (en) 2013-10-29

Similar Documents

Publication Publication Date Title
DK2575795T3 (da) Stabiliseret formulering omfattende omega-3 fedtsyrer og anvendelse af fedtsyrerne til hudpleje og/eller sårpleje
FR21C1021I2 (fr) Compositions d'arni de pcsk9 et methodes d'utilisation associees
IL283173A (en) Human igg1 fc region variants and uses thereof
HRP20170961T1 (hr) Postupak dobivanja karbamoilpiridonskih derivata i međuprodukata
HRP20180872T1 (hr) Životinjska hrana i postupak njezine pripreme
IL240845A0 (en) Compounds and uses thereof for the modulation of hemoglobin
EP2895111A4 (en) MITRALKLAPPENUMKEHRPROTHESE
BR112013023743A2 (pt) anticorpo de fator de tecidos humanos e usos do mesmo
EP2649517A4 (en) Fast computer startup
DE112013002528A5 (de) Kopfhalterung zur Fixierung des Kopfes von Patienten
LT2596786T (lt) Eikozapentaeno rūgšties etilo esterio naudojimas hipertriglicidemijai gydyti
EP2753701A4 (en) Acyl-ACP WACHSESTERSYNTHASEN
DK2451796T3 (da) Tofaanaloger til behandling af dermatologiske lidelser eller tilstande
DK2407151T3 (da) Sammensætning til behandling af hud- og/eller neglelæsioner
EP2658563A4 (en) SEBUM CONTROL AND ANTI-ACNE COMPOSITION
EP2983661A4 (en) FORMULATIONS OF OXABICYCLOHEPTANES AND OXABICYCLOHENDS
DK3470018T3 (da) Kryokonservering af levedygtige menneskehudssubstitutter
EP2583663A4 (en) EMULSION COSMETIC PRODUCT OIL IN WATER FOR SKIN
EP2566439A4 (en) SKIN CONDITIONING COMPOSITIONS CONTAINING 12-HYDROXYSTEARIC ACID
DK2922860T3 (da) Hydrerede og vandfri polymorfer af 2'-o-fucosyllactose samt fremgangsmåder til fremstilling deraf
BR112014016389A8 (pt) composições e uso das mesmas para o tratamento de distúrbios e doenças hepáticas
DK2882290T3 (da) System til at holde liv i og transportere hudbiopsier og anvendelse deraf
HRP20190213T1 (hr) Postupak rastavljanja i/ili sastavljanja podvodnog dijela uvlačive potisne jedinice
DK2836203T3 (da) Vesikulær formulering til anvendelse til behandling af smerter eller nedsat mobilitet i et led
EP2619333A4 (en) PARALLEL SEQUENCING WITH NATIVE EXTENSION